Could things go from bad to worse for Neil Woodford?

Could more underperformance be ahead for Neil Woodford?

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

This year has been one to forget for Neil Woodford. His investment decision-making ability has been questioned by a wide range of investors after a poor performance by his standards. His funds have generally underperformed their benchmarks, and this has led to his reputation suffering at least some damage.

Looking ahead, his fund performance may deliver strong returns in the long run. However, in the short run things could realistically go from bad to worse.

Big calls

One of the major decisions made by Neil Woodford this year has been to sell stakes in long-held companies such as GlaxoSmithKline and British American Tobacco. At the same time, he has purchased a large stake in Lloyds which makes it the fifth biggest holding in his UK Equity Income fund.

While in the long run Lloyds could perform well and deliver high returns, the reality is that the UK economy faces a highly challenging period. Brexit has caused confidence to fall, which has helped to move inflation higher. With consumer spending likely to come under pressure due to falling real disposable incomes, the economic outlook for the UK seems tough. This could hurt the performance of banking stocks such as Lloyds. With the bank operating almost exclusively in the UK, its share price could come under pressure.

Although Lloyds makes up just 3.1% of Neil Woodford’s UK Equity Income fund, his decision to make it one of his top holdings could be scrutinised by investors. Should the bank’s share price fall in the short run, it may be viewed as another ‘error’ by the star fund manager.

Likewise, if Brexit negotiations continue to move along at a slow pace and the pound continues to weaken as the prospect of a ‘no deal’ builds, international stocks such as GlaxoSmithKline and British American Tobacco may see their share prices rise in the short run. Having sold them recently, this could be seen as a further mistake by Woodford.

Long-term potential

Of course, he has been in a similar position before. During the dotcom bubble he was viewed as being out of touch with a new growth avenue. He sat out the bubble and endured criticism for doing so – until it burst and suddenly he was back in fashion once more. Therefore, a similar journey may be ahead this time around.

Certainly, his short-term performance has been disappointing. But the reality is that no investment style, strategy or fund manager can constantly stay ahead of their benchmark. Sometimes one strategy is successful for a period, then events happen and change the market. This can mean what was successful last year is no longer a worthwhile strategy – as was the case regarding the dotcom bubble and subsequent crash.

While things may get worse before they get better for Neil Woodford, in the long run he could be proved right in his decisions. With his reputation being somewhat less impressive than it once was, now could be the perfect time to buy his funds for the long term.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens owns shares in GlaxoSmithKline, British American Tobacco and Lloyds. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended Lloyds Banking Group. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Senior couple crossing the road on a city street. They are walking with shopping bags while Christmas shopping.
Investing Articles

9.4% yield! A magnificent dividend stock I’d buy to target a lifelong second income

Royston Wild’s creating a list of the London stock market's best dividend shares. Here's one he's hoping to buy for…

Read more »

Investing Articles

£17,000 in savings? Here’s how I’d target a weighty passive income

Funnelling any spare savings towards building a passive income is certainly a smart idea, but how to find the right…

Read more »

Investing Articles

Why is this FTSE 250 giant up 35% in two weeks?

Seeing a share price soaring can often be a reason to be cautious, but I still think there's a lot…

Read more »

Light bulb with growing tree.
Investing Articles

Is there still time to snap up this ex-penny stock in May?

A penny stock no more but a promising low-cap company nonetheless. Our writer examines the growth prospects of this sustainable…

Read more »

Close-up of British bank notes
Investing Articles

Here’s how I’d target a £1,890 second income by investing £35 a week

Christopher Ruane explains how, for a fiver a day, he'd aim to build a second income of almost £1,900 in…

Read more »

Dividend Shares

£5k in savings? Here’s how I’d try to turn it into £414 of monthly passive income

Jon Smith explains how he'd use both dividend and growth shares to help him take a lump sum of £5k…

Read more »

Fans of Warren Buffett taking his photo
Investing Articles

Warren Buffett’s sitting on $189bn in cash. What’s this telling us?

Legendary stock market investor Warren Buffett's currently sitting on a cash pile bigger than most FTSE 100 companies. Is this…

Read more »

Typical street lined with terraced houses and parked cars
Dividend Shares

Here’s how much income I’d make if I invested all my ISA in Taylor Wimpey shares

Jon Smith explains why researching Taylor Wimpey shares could be a good move, based on historical dividend payments and the…

Read more »